Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Viruses|December 16, 2020
Toward Tightly Tuned Gene Expression Following Lentiviral Vector TransductionAudrey Page, Floriane Fusil, François-Loïc CossetCancers|April 17, 2020
Towards Physiologically and Tightly Regulated Vectored Antibody TherapiesAudrey Page, Floriane Fusil, François-Loïc CossetJoint Bone Spine|February 22, 2021
Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and futureAudrey Page, Floriane Fusil, François-Loïc CossetInternational Journal of Molecular Sciences|September 28, 2021
Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate TumorsAudrey Page, Julie Hubert, Floriane Fusil, et al.Cellular & Molecular Immunology|March 5, 2024
Development of NK cell-based cancer immunotherapies through receptor engineeringAudrey Page, Nicolas Chuvin, Jenny Valladeau-Guilemond, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 22, 2024
A Synthetic Circuit Empowering Reprogrammed B Cells for Therapeutic Proteins Expression Regulated by Tumor DetectionAudrey Page, Marie Delles, Didier Nègre, et al.Molecular Therapy. Nucleic Acids|June 26, 2023
Engineering B cells with customized therapeutic responses using a synthetic circuitAudrey Page, Marie Delles, Didier Nègre, et al.The Journal of Infectious Diseases|October 12, 2011
Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle releaseOlivier Reynard, Kirill Nemirov, Audrey Page, et al.The Journal of Infectious Diseases|October 12, 2011
Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replicationMathieu Mateo, Caroline Carbonnelle, Miguel J Martinez, et al.Cancer Immunology, Immunotherapy : CII|November 8, 2021
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapiesAudrey Page, Emilie Laurent, Didier Nègre, et al.Pageof 2